DE69919693D1 - Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis - Google Patents

Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis

Info

Publication number
DE69919693D1
DE69919693D1 DE69919693T DE69919693T DE69919693D1 DE 69919693 D1 DE69919693 D1 DE 69919693D1 DE 69919693 T DE69919693 T DE 69919693T DE 69919693 T DE69919693 T DE 69919693T DE 69919693 D1 DE69919693 D1 DE 69919693D1
Authority
DE
Germany
Prior art keywords
polypeptides
basb028
polynucleotids
coding
moraxella catarrhalis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69919693T
Other languages
English (en)
Other versions
DE69919693T2 (de
Inventor
Jean-Louis Ruelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9810379.9A external-priority patent/GB9810379D0/en
Priority claimed from GBGB9909175.3A external-priority patent/GB9909175D0/en
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Application granted granted Critical
Publication of DE69919693D1 publication Critical patent/DE69919693D1/de
Publication of DE69919693T2 publication Critical patent/DE69919693T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69919693T 1998-05-13 1999-05-10 Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis Expired - Fee Related DE69919693T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9810379.9A GB9810379D0 (en) 1998-05-13 1998-05-13 Novel compounds
GB9810379 1998-05-13
GB9909175 1999-04-21
GBGB9909175.3A GB9909175D0 (en) 1999-04-21 1999-04-21 Novel compounds
PCT/EP1999/003263 WO1999058685A2 (en) 1998-05-13 1999-05-10 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis

Publications (2)

Publication Number Publication Date
DE69919693D1 true DE69919693D1 (de) 2004-09-30
DE69919693T2 DE69919693T2 (de) 2005-09-01

Family

ID=26313681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919693T Expired - Fee Related DE69919693T2 (de) 1998-05-13 1999-05-10 Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis

Country Status (8)

Country Link
US (1) US6706494B1 (de)
EP (1) EP1078066B1 (de)
AT (1) ATE274582T1 (de)
AU (1) AU4260299A (de)
CA (1) CA2328429A1 (de)
DE (1) DE69919693T2 (de)
ES (1) ES2228113T3 (de)
WO (1) WO1999058685A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
CA2328429A1 (en) 1999-11-18
EP1078066A2 (de) 2001-02-28
DE69919693T2 (de) 2005-09-01
WO1999058685A2 (en) 1999-11-18
US6706494B1 (en) 2004-03-16
WO1999058685A3 (en) 2000-02-24
ES2228113T3 (es) 2005-04-01
ATE274582T1 (de) 2004-09-15
AU4260299A (en) 1999-11-29
EP1078066B1 (de) 2004-08-25

Similar Documents

Publication Publication Date Title
ATE311457T1 (de) Basb029 polynucleotide und polypeptide aus neisseria meningitis
ATE303442T1 (de) Verbindungen aus moraxella catarrhalis
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
DE69921649D1 (de) Moraxella catarrhalis pilq proteine
PL345193A1 (en) Basb027 proteins and genes from moraxella catarrhalis
ATE397666T1 (de) Neue verbindungen aus moraxella catarrhalis
DE69919693D1 (de) Basb028 polypeptiden und dafür kodierende polynukleotiden aus moraxella catarrhalis
ATE397069T1 (de) Basb205 polypeptide und dafür kodierende polynukleotide
DE60043658D1 (de) Basb118 polypeptid und polynukleotid aus moraxella catarrhalis
ATE360073T1 (de) Basb119 polypeptid und polynukleotid aus moraxella catarrhalis
DE60039303D1 (de) Immunogene polypeptide aus moraxella catarrhalis und deren verwendungen
DE60140006D1 (de) Polypeptide aus haemophilus influenza
ATE293693T1 (de) Moraxella catarrhalis antigen basb117
ATE311458T1 (de) Basb111 polypeptid und polynukleotid aus moraxella catharralis
ATE368686T1 (de) Polypeptide aus moraxella (branhamella) catarrhalis
WO1999058682A3 (en) Compounds from moraxella catarrhalis
DE60019613D1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee